...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

Fair enough, however I would think that all companies would use the word "may" in News Releases while describing a possible MOA and effectiveness of their drug, until that is, they are clinically proven and receive FDA approval?  

Share
New Message
Please login to post a reply